FDA Inspection 1047419 — United Exchange Corp.

United Exchange Corp. — FEI 3013978005

The FDA completed an inspection of United Exchange Corp. on Apr 6, 2018 in Rialto, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Apr 6, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rialto, CA (United States)

Citations

IDCFRDescription
141821 CFR 211.42(c)(7)Quarantined Drug Products Area
435121 CFR 211.160(b)(3)Drug products - samples representative, identified properly

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.